- Matthay, Katherine;
- Kang, MH;
- Villablanca, JG;
- Glade, JL;
- Matthay, KK;
- Groshen, S;
- Sposto, R;
- Czarnecki, S;
- Ames, MM;
- Reynolds, CP;
- Marachelian, A
Background: Patients with relapsed/refractory stage 4 high-risk neuroblastoma were enrolled on a phase I study (NANT2004-03) of intravenous fenretinide emulsion. Pharmacokinetic samples were collected during and after the infusion, and the levels were meas